Tacalcitol

Chemical compound
Revision as of 22:58, 12 April 2024 by Fire (talk | contribs) (Created page with "<languages /> <translate> {{Short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 376121485 | IUPAC_name = (1''S'',3''R'',5''Z'',7''E'',24''R'')-9,10-secocholesta-5,7,10-triene-1,3,24-triol | image = Tacalcitol.svg <!--Clinical data--> | tradename = | Drugs.com = {{drugs.com|international|tacalcitol}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D /...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Tacalcitol (1,24-dihydroxyvitamin D3) is a synthetic vitamin D3 analog. Tacalcitol is marketed under several names, including Curatoderm and Bonalfa.

Tacalcitol
Clinical data
Other names(1α,24R)-1,24-Dihydroxyvitamin D3
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
ChEBI
ChEMBL
Chemical and physical data
FormulaC27H44O3
Molar mass416.646 g·mol−1
3D model (JSmol)
 ☒NcheckY (what is this?)  (verify)

It is on the World Health Organization's List of Essential Medicines.

Mechanism

Tacalcitol reduces excessive cell turnover in the epidermis by interacting with vitamin D receptors on keratinocytes.

Uses

It is usually prescribed by a general practitioner or dermatologist for the treatment of psoriasis, chronic chapped lips and other severe dry skin conditions because of its ability to reduce excessive skin cell turnover.[1] It is available as an ointment or lotion.

It has also been used for vitiligo and Hailey-Hailey disease.


  1. Cite error: Invalid <ref> tag; no text was provided for refs named pmid9257082